Cargando…
Statin-Induced Geranylgeranyl Pyrophosphate Depletion Promotes PCSK9–Dependent Adipose Insulin Resistance
Statin treatment is accepted to prevent adverse cardiovascular events. However, statin therapy has been reported to be dose-dependently associated with increased risk for new-onset type 2 diabetes mellitus (T2DM). Proprotein convertase subtilisin/kexin type 9 (PCSK9) is expressed in adipose tissue a...
Autores principales: | Shu, Xin, Wu, Jiaqi, Zhang, Tao, Ma, Xiaoyu, Du, Zuoqin, Xu, Jin, You, Jingcan, Wang, Liqun, Chen, Ni, Luo, Mao, Wu, Jianbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853319/ https://www.ncbi.nlm.nih.gov/pubmed/36558473 http://dx.doi.org/10.3390/nu14245314 |
Ejemplares similares
-
Statin-Induced Geranylgeranyl Pyrophosphate Depletion Promotes Ferroptosis-Related Senescence in Adipose Tissue
por: Shu, Xin, et al.
Publicado: (2022) -
Geranylgeranyl pyrophosphate depletion by statins compromises skeletal muscle insulin sensitivity
por: Wang, Lai, et al.
Publicado: (2022) -
Statin-induced depletion of geranylgeranyl pyrophosphate inhibits cell proliferation by a novel pathway of Skp2 degradation
por: Vosper, Jonathan, et al.
Publicado: (2014) -
Effects of mevalonate kinase interference on cell differentiation, apoptosis, prenylation and geranylgeranylation of human keratinocytes are attenuated by farnesyl pyrophosphate or geranylgeranyl pyrophosphate
por: Li, Min, et al.
Publicado: (2020) -
Interactions between PCSK9 and NLRP3 inflammasome signaling in atherosclerosis
por: Wang, Yanan, et al.
Publicado: (2023)